CLT-21 COMBAT-ALS phase 2b/3 trial of MN-166 (ibudilast) in ALS: trial update and baseline characteristics
Publication/Presentation Date
11-2025
Volume
26
Issue
2
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS